Results 61 to 70 of about 3,073 (139)

A review on simultaneous method development approach for Empagliflozin and Sitagliptin phosphate

Pharmaceutical analysis plays a crucial role during the whole process of drug development, from formulating new medications to stability testing and quality control. It helps us understand the content of different dosage forms, both quantitatively and qualitatively.
openaire   +2 more sources

Preparation And Evaluation Oral Buccal Patches Of Sitagliptin Phosphate As Antidiabetic Drug

The study focuses on the development and evaluation of oral buccal patches containing Sitagliptin Phosphate, an antidiabetic drug, aimed at providing a controlled and effective delivery system for diabetes management. Sitagliptin Phosphate, a widely used DPP-4 inhibitor, was incorporated into buccal patches designed for mucosal absorption, offering a ...
openaire   +1 more source

Oligomers-model building in protonation equilibria of sitagliptin

Open Chemistry, 2013
Meloun Milan, Ferenčíková Zuzana, Niesnerová Irena, Pekárek Tomáš   +3 more
doaj   +1 more source

FORMULATION AND IN-VITRO AND IN-VIVO EVALUATION OF CONTROLLED RELEASE TABLET OF SITAGLIPTIN PHOSPHATE AS AN ANTIDIABETIC DRUG: A REVIEW

The development of controlled-release (CR) formulations of sitagliptin phosphate is a significant advancement in the management of type 2 diabetes mellitus (T2DM). Sitagliptin phosphate, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is widely used for improving glycemic control by enhancing incretin hormone levels. However, its short half-life (~12 hours)
Mhaske N. S, Kedar P. S
openaire   +2 more sources

Development and Validation of Analytical Methods for Simultaneous Estimation of Sitagliptin Phosphate and Pioglitazone Hydrochloride [PDF]

International Journal for Pharmaceutical Research Scholars, 2018
K. G. Vaishnavi, S. T. Varsha, M. T. Nirmal, A. P. Somnath, S. K. Mallinath   +4 more
openaire   +1 more source

Maculopapular-Type Drug Eruption Caused by Sitagliptin Phosphate Hydrate: A Case Report and Mini-Review of the Published Work

Allergology International, 2014
Noriaki Nakai, Norito Katoh
doaj   +1 more source

Eyedrop Administration of DPP-4 Inhibitors: A New Strategy for Treating Early Stages of Diabetic Retinal Disease. [PDF]

Int J Mol Sci
Ramos H, Simó-Servat O, Hernández C, Simó R.   +3 more
europepmc   +1 more source

FORMULATION AND EVALUTION OF SUSTAINED RELEASE BILAYER TABLET OF GLICAZIDE, PIOGLITAZONE HCL, AND SITAGLIPTIN PHOSPHATE

Diabetes Mellitus 2 is a progressive metabolic disease that has Insulin Resistance and impaired insulin secretion. T2DM usually produces prolonged high blood glucose levels (hyperglycaemia), which makes medication to treat T2DM require combining different types of medication over time. The research described in this paper evaluates the performance of a
openaire   +2 more sources

Eco-friendly second-derivative synchronous fluorescence method for the determination of empagliflozin and sitagliptin in tablets and plasma samples. [PDF]

Sci Rep
Mohamad AAA, Almrasy AA, Abdelazim AH, Taha AS.   +3 more
europepmc   +1 more source

Sitagliptin Modulates Functional and Phenotypic Properties of Human Neutrophils Under Normal- and High-Glucose Conditions In Vitro. [PDF]

Molecules
Mališ V, Drakul M, Rakočević S, Kozić L, Dubovina A, Popović D, Bokonjić D, Mihajlović D, Čolić M.   +8 more
europepmc   +1 more source